SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department

BACKGROUND: In the emergency department (ED) setting, rapid testing for SARS-CoV-2 is likely associated with advantages to patients and healthcare workers, for example, enabling early but rationale use of limited isolation resources. Most recently, several SARS-CoV-2 rapid point-of-care antigen test...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Biomarkers
Autores principales: Möckel, Martin, Corman, Victor M., Stegemann, Miriam S., Hofmann, Jörg, Stein, Angela, Jones, Terry C., Gastmeier, Petra, Seybold, Joachim, Offermann, Ralf, Bachmann, Ulrike, Lindner, Tobias, Bauer, Wolfgang, Drosten, Christian, Rosen, Alexander, Somasundaram, Rajan
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2021
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7898296/
https://ncbi.nlm.nih.gov/pubmed/33455451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/1354750X.2021.1876769
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares